Dr. Céline Gounder, an internist, epidemiologist and infectious disease specialist, is a CBS News medical contributor as well as senior fellow and editor-at-large for public health at KFF Health News.

Big news in the menopause world: The Food and Drug Administration has just approved the drug elinzanetant as a non-hormonal treatment for hot flashes. The medication, which will be marketed under the ...

ACCORDINGLY. BACK TO YOU, MY FRIEND. THANKS, CORY. FOR MANY WOMEN, HOT FLASHES AND NIGHT SWEATS CAN MAKE MENOPAUSE A REAL CHALLENGE. THE FDA JUST APPROVED A NEW NON-HORMONAL DRUG TO HELP KOAT UNM ...

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes, common during menopause. The drug, known ...

The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...

The U.S. Food and Drug Administration will remove the “black box” warning labels on many hormone therapy drugs used for menopause and perimenopause symptoms — a major turnaround that’s likely to ...

From hacking hot flashes to postponing menopause altogether, here’s what’s on the horizon.

October 18 is World Menopause Day and let’s talk about something all women—half the world’s population—will eventually experience: menopause. Even though it’s a huge part of being a woman, many of us ...

In postmenopausal women, combining menopausal hormone therapy with tirzepatide resulted in markedly greater weight loss than ...

The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes. The drug, known generically as elinzanetant, is ...